Sort
48,018 grants matching “immunotherapy”
Impact of RB activation on the pancreatic cancer epigenome and tumor microenvironment
$505,216Agnieszka Witkiewicz · Roswell Park Cancer Institute Corp · R01 · FY2025 · CA
Exploring novel therapeutic strategies for combinatory therapy to treat renal clear cell carcinomas
$505,159Weizhou Zhang · University Of Florida · R01 · FY2023 · CA
Identify the host genetic determinants of immune response and TB countrol
$505,084Ildiko Vanrhijn · Brigham And Women'S Hospital · U19 · FY2020 · AI
Fecal Microbiota Transplant and PD-1 blockade in Melanoma
$505,070Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
HIV VACCINE DESIGN AND DEVELOPMENT TEAMS (HVD
$505,050Charles Nicolette · Argos Therapeutics, Inc. · N01 · FY2014 · AI
Synthetics PNAG and multi-component vaccines against emerging pathogens
$505,031Gerald B Pier · Harvard Medical School · U54 · FY2010 · AI
Designing T cells to Functionally Cure HIV-1 infection
$505,007James L Riley · University Of Pennsylvania · U19 · FY2015 · AI
Defining the role of NF1 and SPRED1 loss in melanoma
$504,988Iwei Yeh · University Of California, San Francisco · R37 · FY2020 · CA
ANTIVIRAL &ANTIFIBROTIC LIVER THERAPY OF HCV+ DRINKERS
$504,984Mount Sinai School Of Medicine Of Nyu · R01 · FY2000 · AA
Systems Biology of Antigen and T-Cell Transport in Cancer Immunotherapy
$504,978Timothy P Padera · Massachusetts General Hospital · R01 · FY2023 · CA
Core C: Correlative Sciences PDCS/TCSL
$504,946Jan J Melenhorst · University Of Pennsylvania · P01 · FY2018 · CA
Novel Strategies for Precision T-cell Therapies
$504,946Steven C. Almo · Albert Einstein College Of Medicine · R01 · FY2019 · CA
An Environmental Chemical Receptor, the AhR, as a Mediator of Multiple Immune Checkpoints in Oral Cancer
$504,865David H Sherr · Boston University Medical Campus · R01 · FY2023 · ES
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
$504,843Manuel L Penichet · University Of California Los Angeles · R01 · FY2016 · CA
A New Paradigm to Prevent and Treat Micrometastases
$504,838Timothy P Cripe · Research Inst Nationwide Children'S Hosp · R01 · FY2024 · CA
Adjunct rhIL-12 enhance THI response to viral vaccine?
$504,807University Of California San Francisco · R01 · FY2002 · AI
Mechanisms controlling the persistence of infectious HIV reservoirs in children
$504,787Lisa M Frenkel · Seattle Children'S Hospital · R01 · FY2017 · HD
Modeling Antibody-induced Immune Responses by NK cells in Mice and Humans (Resubmission 1)
$504,785Jayajit Das · Research Inst Nationwide Children'S Hosp · R01 · FY2021 · AI
TRANSLATIONAL CLINICAL TRIALS FOR PRIMARY CNS TUMORS
$504,772David Reardon · Duke University · P50 · FY2011 · NS
Mechanisms of increased susceptibility to TB in HIV-Infected individuals
$504,771David H Canaday · Case Western Reserve University · R01 · FY2013 · AI
Project 3: Chemotherapy and Immunotherapy Biomarker Development for Triple Negative Breast Cancer
$504,759Charles M Perou · Univ Of North Carolina Chapel Hill · P50 · FY2018 · CA
Basic Medical Research Training in Oncology
$504,732Olufunmilayo I Olopade · University Of Chicago · T32 · FY2020 · CA
Cooperation of the TAM and Abl family kinases in therapeutic resistance in HNC
$504,584Deric L Wheeler · University Of Wisconsin-Madison · R01 · FY2022 · CA
The Tumor Microenvironment Niche of Type I conventional Dendritic Cells
$504,511Matthew F Krummel · University Of California, San Francisco · R01 · FY2024 · CA
CAREER: Development of DNA nanocarriers to redirect immune cells toward chosen targets
$504,492Matthias Stephan · Fred Hutchinson Cancer Research Center · · FY2015 · ENG